KRAS as a Modulator of the Inflammatory Tumor Microenvironment: Therapeutic Implications

KRAS mutations are one of the most frequent oncogenic mutations of all human cancers, being more prevalent in pancreatic, colorectal, and lung cancers. Intensive efforts have been encouraged in order to understand the effect of KRAS mutations, not only on tumor cells but also on the dynamic network...

Descripción completa

Detalles Bibliográficos
Autores principales: Pereira, Flávia, Ferreira, Anabela, Reis, Celso Albuquerque, Sousa, Maria João, Oliveira, Maria José, Preto, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833974/
https://www.ncbi.nlm.nih.gov/pubmed/35159208
http://dx.doi.org/10.3390/cells11030398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833974/
https://www.ncbi.nlm.nih.gov/pubmed/35159208
http://dx.doi.org/10.3390/cells11030398

Ejemplares similares